Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

Sanofi and CD&R enter exclusive agreement for Opella sale, and promise to keep jobs in France

French pharma giant Sanofi and US PE firm Clayton Dubilier & Rice (CD&R) have been made to sign a promise to the French government to keep factories and jobs in France after the sale of a 50% stake in Sanofi's consumer health division, Opella, to CD&R. Sanofi and CD&R are now in exclusive talks for the sale, in a deal which is valuing Opella at $16.4 billion.
October 25, 2024

India’s healthcare IPO market grows, presenting fresh opportunities for investors

Niva Bupa Health Insurance, an India-based health insurance firm backed by private equity firm True North, and Paras Healthcare, one of the top Indian private hospitals, have received the Securities and Exchange Board of India’s (SEBI) approval to launch Initial Public Offerings (IPOs). Niva Bupa aims to raise ₹3,000 crore ($361 million USD), comprising Rs 800 crore ($96.4 million USD), through fresh equity and ₹2,200 crore ($264 million USD) via an Offer for Sale (OFS). The Times of India reported in July 2024 that Niva Bupa is “the second standalone health insurer to file an IPO, after Star Health & Allied Insurance Company”, India’s leading health insurer. 
October 25, 2024

Parkway Life acquires 11 nursing homes in France from DomusVi

Parkway Life Real Estate Investment Trust (PLife REIT), one of Asia’s largest listed healthcare REITs, has acquired 11 nursing homes in France in a sale and leaseback arrangement for €111.2m (roughly S$159.9 million) from DomusVi, one of Europe’s largest nursing and retirement home providers. The deal marks PLife REIT’s maiden acquisition in Europe, as part of its long-term strategy to grow its presence in the region and the UK. 
October 25, 2024

The UK and Europe set for increased PE investment and value chain consolidation in digital health — Rob Sher, Alvarez & Marsal

Europe, especially the UK, is seeing rising private equity interest and larger companies entering the digital health sector. Deal volumes are expected to grow as providers consolidate across the value chain.  The global digital health sector on the whole is increasingly attractive for private equity investments, with experts predicting a surge in M&A deals over the coming months.
October 18, 2024

Sanofi deal row a “non-event” indicating French politicians’ “lack of maturity in handling cross-border M&A deals”

On October 11, Reuters reported that Sanofi, the French drugmaker, is negotiating a sale of a 50% stake in its consumer health business, Opella, to US private equity firm Clayton Dubilier & Rice (CD&R). The negotiation is valuing the business at €16.4 billion. This move is part of Sanofi's strategy to separate its consumer healthcare segment to fund new drug development.
October 18, 2024

WhiteCoat acquires Good Doctor, creating Southeast Asia’s “largest digital healthcare group”

Singapore-based digital healthcare group WhiteCoat Global is acquiring Good Doctor Indonesia, a telemedicine platform with the largest insurer and corporate client network in Indonesia. WhiteCoat, which connects patients with payers and providers to deliver primary, specialist, and allied care, said in a statement the ‘landmark deal will create the region’s largest and most comprehensive digital healthcare group’. Thalia Georgiou, Managing Partner, Healthcare Advisory at Asia Care Group, also offers her perspective on the deal.
October 17, 2024

Why pharma services is such an attractive investment space

Last week Telemos Capital, a European mid-market private equity firm backed by family capital, bought Helios Global Group, a full-service global healthcare communications provider, from NorthEdge, a regional lower mid-market private equity company. We spoke with one of the deal's advisors — Tom Cowap, Managing Director at Baird, an employee-owned international investment bank — about how this is a bellwether for growing private equity interest in the med comms and wider pharma services space.
October 10, 2024

More than 80% of healthcare business leaders and 86% of investors expect to see an increase in investment, according to new report

International law firm Simmons & Simmons has published new research on how leaders at Europe’s largest healthcare companies and sector investors view the future of the health and life sciences (HLS), revealing robust confidence in the for-profit European healthcare sector.  The report surveyed more than 700 senior executives and major investors across the continent representing multi-billion dollar companies.  “The healthcare and life sciences sector is currently undergoing a significant shift. Technological developments, demographic changes and advancements in research and medicine are beginning to transform the sector, creating entirely new opportunities for investors,” Simmons & Simmons partner Simonetta Giordano told HBI.
October 9, 2024
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us